{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:24:01Z","timestamp":1780467841268,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jval.2015.06.006","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T16:25:42Z","timestamp":1442075142000},"page":"404-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales"],"prefix":"10.1016","volume":"19","author":[{"given":"Rachid","family":"Rafia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm W.R.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gill","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thompson","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Wyld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2015.06.006_bib1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1532-5415.2004.52119.x","article-title":"Screening and cognitive impairment: ethics of forgoing mammography in older women","volume":"52","author":"Raik","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jval.2015.06.006_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","article-title":"ABC of breast disease: breast cancer-epidemiology, risk factors, and genetics","volume":"321","author":"McPherson","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2015.06.006_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1634\/theoncologist.2010-0234","article-title":"Lack of survival gain for elderly women with breast cancer","volume":"16","author":"Bastiaannet","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.jval.2015.06.006_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/annonc\/mdp301","article-title":"Treatment and survival in breast cancer in the eastern region of England","volume":"21","author":"Wishart","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jval.2015.06.006_bib5","first-page":"1230","article-title":"Reed MWR. Stage and treatment variation with age in postmenopausal women with breast cancer","volume":"91","author":"Wyld","year":"2004","journal-title":"Br J Med Surg"},{"key":"10.1016\/j.jval.2015.06.006_bib6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/sj.bjc.6603709","article-title":"Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or = 65 years","volume":"96","author":"Lavelle","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jval.2015.06.006_bib7","doi-asserted-by":"crossref","first-page":"13274","DOI":"10.1073\/pnas.0804931105","article-title":"Exceptional longevity does not result in excessive levels of disability","volume":"105","author":"Christensen","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jval.2015.06.006_bib8","article-title":"All Breast Cancer Report: A UK Analysis of all Symptomatic and Screen Detected Breast Cancers Diagnosed in 2006","author":"Cheung","year":"2009","journal-title":"NHS Cancer Screening Programmes"},{"key":"10.1016\/j.jval.2015.06.006_bib9","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.bjc.6604368","article-title":"Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?","volume":"98","author":"Wishart","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jval.2015.06.006_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10552-009-9459-z","article-title":"Estimates of overdiagnosis of invasive breast cancer associated with screening mammography","volume":"21","author":"Morrell","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jval.2015.06.006_bib11","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(03)13143-1","article-title":"Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening","volume":"361","author":"Tabar","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2015.06.006_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","article-title":"Long-term effects of mammography screening: updated overview of the Swedish randomised trials","volume":"359","author":"Nystrom","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2015.06.006_bib13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1349-7006.2009.01147.x","article-title":"Cost-effective mammography screening in Korea: high incidence of breast cancer in young women","volume":"100","author":"Lee","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jval.2015.06.006_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1524-4733.2007.00244.x","article-title":"Gaussian process metamodeling in Bayesian value of information analysis: a case of the complex health economic model for breast cancer screening","volume":"11","author":"Rojnik","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2015.06.006_bib15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/cncr.22848","article-title":"Cost effectiveness of mammography screening for Chinese women","volume":"110","author":"Wong","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jval.2015.06.006_bib16","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/jnci\/djj210","article-title":"Retrospective cost-effectiveness analysis of screening mammography","volume":"98","author":"Stout","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jval.2015.06.006_bib17","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1349-7006.2006.00296.x","article-title":"Cost-effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40\u201349 years","volume":"97","author":"Ohnuki","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jval.2015.06.006_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1525-1497.2005.0116.x","article-title":"Toward optimal screening strategies for older women: costs, benefits, and harms of breast cancer screening by age, biology, and health status","volume":"20","author":"Mandelblatt","year":"2005","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jval.2015.06.006_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7326\/0003-4819-139-10-200311180-00011","article-title":"The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force","volume":"139","author":"Mandelblatt","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2015.06.006_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1524-4733.2009.00667.x","article-title":"A rapid-response economic evaluation of the UK NHS Cancer Reform Strategy breast cancer screening program extension via a plausible bounds approach","volume":"13","author":"Madan","year":"2010","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2015.06.006_bib21","series-title":"Option Appraisal: Modelling the Effectiveness and Cost-Effectiveness of Screening Policies for Breast Cancer in Elderly Women in England and Wales","author":"Rafia","year":"2011"},{"key":"10.1016\/j.jval.2015.06.006_bib22","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/cncr.11765","article-title":"The effect of tumor size and lymph node status on breast carcinoma lethality","volume":"98","author":"Michaelson","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jval.2015.06.006_bib23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/sim.2550","article-title":"A natural history model of stage progression applied to breast cancer","volume":"26","author":"Plevritis","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.jval.2015.06.006_bib24","unstructured":"Eastern Cancer Registry Information Centre registry data. Data on file 2010."},{"key":"10.1016\/j.jval.2015.06.006_bib25","unstructured":"West Midlands Cancer Intelligence Unit registry data. Data on file 2010."},{"key":"10.1016\/j.jval.2015.06.006_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10549-008-0289-6","article-title":"Comparing the cost of adjuvant anastrozole with the benefits of managing less patients with relapsed breast cancer","volume":"117","author":"Thomas","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jval.2015.06.006_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2354.2005.00623.x","article-title":"Palliative care treatment patterns and associated costs of healthcare resource use for specific advanced cancer patients in the UK","volume":"15","author":"Guest","year":"2006","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.jval.2015.06.006_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clon.2008.12.008","article-title":"Early and locally advanced breast cancer: diagnosis and treatment. National Institute for Health and Clinical Excellence Guideline 2009","volume":"21","author":"Yarnold","year":"2009","journal-title":"Clin Oncol"},{"key":"10.1016\/j.jval.2015.06.006_bib29","unstructured":"National Health Service Breast Screening Programme. Breast Screening Results from the NHSBSP 2007\/2008. Cancer Screening Evaluation Unit, 2009. Available from: http:\/\/www.cancerscreening.nhs.uk. [Accessed August 24, 2015]"},{"key":"10.1016\/j.jval.2015.06.006_bib30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1525-1497.2006.00609.x","article-title":"Can differences in breast cancer utilities explain disparities in breast cancer care?","volume":"21","author":"Schleinitz","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jval.2015.06.006_bib31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/bmj.316.7133.736","article-title":"Variations in population health status: results from a United Kingdom national questionnaire survey","volume":"316","author":"Kind","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2015.06.006_bib32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11136-008-9353-2","article-title":"Quality of life valuations of mammography screening","volume":"17","author":"Bonomi","year":"2008","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2015.06.006_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.bjc.6601912","article-title":"Impact of screening for breast cancer in high-risk women on health-related quality of life","volume":"91","author":"Rijnsburger","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jval.2015.06.006_bib34","unstructured":"National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisals. National Institute for Clinical Excellence, 2008. Available from: http:\/\/www.nice.org.uk\/. [Accessed August 24, 2015]."},{"key":"10.1016\/j.jval.2015.06.006_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1524-4733.2007.00223.x","article-title":"Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia","volume":"11","author":"Rojnik","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2015.06.006_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5694\/j.1326-5377.2002.tb04405.x","article-title":"Benefits, harms and costs of screening mammography in women 70 years and over: a systematic review","volume":"176","author":"Barratt","year":"2002","journal-title":"Med J Aust"},{"key":"10.1016\/j.jval.2015.06.006_bib37","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0959-8049(00)00099-X","article-title":"Prevalence of complementary therapy use by women with breast cancer: a population-based survey","volume":"36","author":"Rees","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jval.2015.06.006_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/epirev\/mxr009","article-title":"Interpreting overdiagnosis estimates in population-based mammography screening","volume":"33","author":"de Gelder","year":"2011","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.jval.2015.06.006_bib39","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"380","author":"Marmot","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2015.06.006_bib40","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1470-2045(07)70380-7","article-title":"Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review","volume":"8","author":"Biesheuvel","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jval.2015.06.006_bib41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/0272989X10384738","article-title":"Bayesian calibration of a natural history model with application to a population model for colorectal cancer","volume":"31","author":"Whyte","year":"2011","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2015.06.006_bib42","doi-asserted-by":"crossref","first-page":"f385","DOI":"10.1136\/bmj.f385","article-title":"Harms from breast cancer screening outweigh benefits if death caused by treatment is included","volume":"346","author":"Baum","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2015.06.006_bib43","unstructured":"Department of Health. NHS Reference Costs 2006-07. Department of Health, 2008. Available from: http:\/\/www.dh.gov.uk\/. [Accessed August 24, 2015]"},{"key":"10.1016\/j.jval.2015.06.006_bib44","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2214\/AJR.07.3861","article-title":"Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis","volume":"191","author":"Pandharipande","year":"2008","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jval.2015.06.006_bib45","first-page":"1","article-title":"A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population: the PRIME trial","volume":"11","author":"Prescott","year":"2007","journal-title":"Health Technol Assess (Winchester, England)"},{"key":"10.1016\/j.jval.2015.06.006_bib46","first-page":"1","article-title":"Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in breast cancer: systematic review and economic evaluation","volume":"15:iii\u2013iv","author":"Cooper","year":"2011","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jval.2015.06.006_bib47","unstructured":"Department of Health. NHS Reference Costs 2008-09. Department of Health, 2010. Available from: http:\/\/www.dh.gov.uk\/. [Accessed August 24, 2015]."},{"key":"10.1016\/j.jval.2015.06.006_bib48","unstructured":"Department of Health. NHS Reference Costs 2005-06. Department of Health, 2006. Available from: http:\/\/www.dh.gov.uk\/. [Accessed August 24, 2015]."},{"key":"10.1016\/j.jval.2015.06.006_bib49","series-title":"A Cost Comparison of Full Field Digital Mammography (FFDM) With Film-Screen Mammography in Breast Cancer Screening. NHSBSP Equipment Report 0403","author":"Legood","year":"2004"},{"key":"10.1016\/j.jval.2015.06.006_bib50","unstructured":"Johnston K, Gerard K, Morton A, Brown J: NHS Costs for the Breast Screening Frequency and Age Trials. Health Economics Research Group Discussion paper number 16 Brunel University, 1996"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301515019920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301515019920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T07:29:59Z","timestamp":1599550199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301515019920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1098301515019920"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2015.06.006","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2015.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by International Society for Pharmacoeconomics and Outcomes Research (ISPOR)","name":"copyright","label":"Copyright"}]}}